retatrutide trial results october 2025 Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a I personally know plenty of

What is binge eating disorder, and why has it been so hard to treat

FDA-labeled warnings include: Risk of thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) Pancreatitis (report severe abdominal pain, with or without vomiting) Gallbladder disease (including gallstones and cholecystitis) Acute kidney injury secondary to dehydration from gastrointestinal symptoms Hypoglycemia when used with insulin or insulin secretagogues (dose adjustments may be needed) Diabetic retinopathy complications in patients with type 2 diabetes and pre-existing retinopathy Suicidal behavior and ideation (monitor for depression or suicidal thoughts) Intestinal obstruction/ileus (particularly with severe constipation) These medications are contraindicated during pregnancy and should be discontinued at least two months before a planned pregnancy

Other combinations have reached as much as 20 percent on higher doses

So clever naming there

When people ask what is the strongest GLP-1 for weight loss, the wording can be imprecise

What should I do if my medication looks cloudy